MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus
Clinical trial NCT03567824 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT03567824
- Sponsor
- Pharmalyte Solutions LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2028-04-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.